Form 4: MACOM Technology Solutions Director Susan Ocampo Sells Shares

Sentiment:

SEC Form 4 Filing


Director Susan Ocampo sold shares of MACOM Technology Solutions Holdings, Inc. on February 27 and 29, 2024.

Summary

  • Susan Ocampo, a director of MACOM Technology Solutions Holdings, Inc., reported the sale of company stock.
  • On February 27, 2024, she sold 4,370 shares at a weighted average price of $88.03, with prices ranging from $88.00 to $88.20.
  • On February 29, 2024, she sold 34,186 shares at a weighted average price of $88.00, with prices ranging from $88.00 to $88.14.
  • Following these transactions, Ocampo indirectly owns 6,886,661 shares through the Ocampo Family Trust.
  • She also indirectly owns 7,987,681 shares through trusts for her children.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a company director. The sentiment is neutral as it simply reports a transaction without expressing any opinion or outlook.

Industry Context

This is a routine disclosure of insider trading activity. It's important to monitor such filings to understand the sentiment of company insiders regarding the stock's valuation and future prospects.

Stakeholder Impact

  • The sale of shares by a director could be perceived negatively by some shareholders, potentially leading to a slight decrease in investor confidence.

Key Dates

DateDescription
02/27/2024Susan Ocampo sold 4,370 shares of MACOM Technology Solutions Holdings, Inc.
02/29/2024Susan Ocampo sold 34,186 shares of MACOM Technology Solutions Holdings, Inc.
02/29/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.